Epidemiological characteristics and immune status of children with Respiratory Syncytial Virus

Respiratory Syncytial Virus (RSV) infections are the dominant cause of pneumonia in children. In order to determine the epidemiological characteristics and immune status of children with Respiratory Syncytial Virus, a prospective study was performed among patients with RSV infection. Comparisons bet...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical virology Vol. 87; no. 2; pp. 323 - 329
Main Authors Ye, Qing, Shao, Wen-Xia, Shang, Shi-Qiang, Pan, Yan-Xiang, Shen, Hong-Qiang, Chen, Xue-Jun
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.02.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Respiratory Syncytial Virus (RSV) infections are the dominant cause of pneumonia in children. In order to determine the epidemiological characteristics and immune status of children with Respiratory Syncytial Virus, a prospective study was performed among patients with RSV infection. Comparisons between RSV pneumonia group and normal control group, RSV pneumonia group had lower IL‐2 (median levels, pg/ml: 3.8 vs. 5.1, P < 0.01), and higher IL‐4 (median levels, pg/ml: 3.2 vs. 2.4, P < 0.01), IL‐10 (median levels, pg/ml: 12.2 vs. 2.3, P < 0.01), and IFN‐γ (median levels, pg/ml: 13.4 vs. 4.6, P < 0.01). The level of IgE among pneumonia patients caused by RSV increased sharply (median levels, mg/L: 48.1 vs. 8.8, P < 0.01). Another amazing finding is that after birth, the degree of IgE of the children infected by RSV increases gradually with age. This effect is at its peak in 0.6 years old. The IgE and eosinophil levels were higher when patients suffered from RSV pneumonia with wheeze (IgE median levels, IU/ml: with wheeze: 72.74 vs. without wheeze: 11.5, P < 0.05; eosinophil median levels, ×109/l: with wheeze: 0.21 vs. without wheeze: 0.05, P < 0.05). The main morbidity crowd is the children under the age of 1 year old. The downregulation of IL2 and the upregulation of IL‐4, IL‐10, IFN‐γ, and IgE happen after RSV infection. J. Med. Virol. 87:323–329, 2015. © 2014 Wiley Periodicals, Inc.
AbstractList Respiratory Syncytial Virus (RSV) infections are the dominant cause of pneumonia in children. In order to determine the epidemiological characteristics and immune status of children with Respiratory Syncytial Virus, a prospective study was performed among patients with RSV infection. Comparisons between RSV pneumonia group and normal control group, RSV pneumonia group had lower IL-2 (median levels, pg/ml: 3.8 vs. 5.1, P<0.01), and higher IL-4 (median levels, pg/ml: 3.2 vs. 2.4, P<0.01), IL-10 (median levels, pg/ml: 12.2 vs. 2.3, P<0.01), and IFN-[gamma] (median levels, pg/ml: 13.4 vs. 4.6, P<0.01). The level of IgE among pneumonia patients caused by RSV increased sharply (median levels, mg/L: 48.1 vs. 8.8, P<0.01). Another amazing finding is that after birth, the degree of IgE of the children infected by RSV increases gradually with age. This effect is at its peak in 0.6 years old. The IgE and eosinophil levels were higher when patients suffered from RSV pneumonia with wheeze (IgE median levels, IU/ml: with wheeze: 72.74 vs. without wheeze: 11.5, P<0.05; eosinophil median levels, ×109/l: with wheeze: 0.21 vs. without wheeze: 0.05, P<0.05). The main morbidity crowd is the children under the age of 1 year old. The downregulation of IL2 and the upregulation of IL-4, IL-10, IFN-[gamma], and IgE happen after RSV infection. J. Med. Virol. 87:323-329, 2015. © 2014 Wiley Periodicals, Inc.
Respiratory Syncytial Virus (RSV) infections are the dominant cause of pneumonia in children. In order to determine the epidemiological characteristics and immune status of children with Respiratory Syncytial Virus, a prospective study was performed among patients with RSV infection. Comparisons between RSV pneumonia group and normal control group, RSV pneumonia group had lower IL-2 (median levels, pg/ml: 3.8 vs. 5.1, P<0.01), and higher IL-4 (median levels, pg/ml: 3.2 vs. 2.4, P<0.01), IL-10 (median levels, pg/ml: 12.2 vs. 2.3, P<0.01), and IFN- gamma (median levels, pg/ml: 13.4 vs. 4.6, P<0.01). The level of IgE among pneumonia patients caused by RSV increased sharply (median levels, mg/L: 48.1 vs. 8.8, P<0.01). Another amazing finding is that after birth, the degree of IgE of the children infected by RSV increases gradually with age. This effect is at its peak in 0.6 years old. The IgE and eosinophil levels were higher when patients suffered from RSV pneumonia with wheeze (IgE median levels, IU/ml: with wheeze: 72.74 vs. without wheeze: 11.5, P<0.05; eosinophil median levels, 10 super(9)/l: with wheeze: 0.21 vs. without wheeze: 0.05, P<0.05). The main morbidity crowd is the children under the age of 1 year old. The downregulation of IL2 and the upregulation of IL-4, IL-10, IFN- gamma , and IgE happen after RSV infection. J. Med. Virol. 87:323-329, 2015. copyright 2014 Wiley Periodicals, Inc.
Respiratory Syncytial Virus (RSV) infections are the dominant cause of pneumonia in children. In order to determine the epidemiological characteristics and immune status of children with Respiratory Syncytial Virus, a prospective study was performed among patients with RSV infection. Comparisons between RSV pneumonia group and normal control group, RSV pneumonia group had lower IL-2 (median levels, pg/ml: 3.8 vs. 5.1, P < 0.01), and higher IL-4 (median levels, pg/ml: 3.2 vs. 2.4, P < 0.01), IL-10 (median levels, pg/ml: 12.2 vs. 2.3, P < 0.01), and IFN-γ (median levels, pg/ml: 13.4 vs. 4.6, P < 0.01). The level of IgE among pneumonia patients caused by RSV increased sharply (median levels, mg/L: 48.1 vs. 8.8, P < 0.01). Another amazing finding is that after birth, the degree of IgE of the children infected by RSV increases gradually with age. This effect is at its peak in 0.6 years old. The IgE and eosinophil levels were higher when patients suffered from RSV pneumonia with wheeze (IgE median levels, IU/ml: with wheeze: 72.74 vs. without wheeze: 11.5, P < 0.05; eosinophil median levels, ×10(9) /l: with wheeze: 0.21 vs. without wheeze: 0.05, P < 0.05). The main morbidity crowd is the children under the age of 1 year old. The downregulation of IL2 and the upregulation of IL-4, IL-10, IFN-γ, and IgE happen after RSV infection.
Respiratory Syncytial Virus (RSV) infections are the dominant cause of pneumonia in children. In order to determine the epidemiological characteristics and immune status of children with Respiratory Syncytial Virus, a prospective study was performed among patients with RSV infection. Comparisons between RSV pneumonia group and normal control group, RSV pneumonia group had lower IL‐2 (median levels, pg/ml: 3.8 vs. 5.1, P < 0.01), and higher IL‐4 (median levels, pg/ml: 3.2 vs. 2.4, P < 0.01), IL‐10 (median levels, pg/ml: 12.2 vs. 2.3, P < 0.01), and IFN‐γ (median levels, pg/ml: 13.4 vs. 4.6, P < 0.01). The level of IgE among pneumonia patients caused by RSV increased sharply (median levels, mg/L: 48.1 vs. 8.8, P < 0.01). Another amazing finding is that after birth, the degree of IgE of the children infected by RSV increases gradually with age. This effect is at its peak in 0.6 years old. The IgE and eosinophil levels were higher when patients suffered from RSV pneumonia with wheeze (IgE median levels, IU/ml: with wheeze: 72.74 vs. without wheeze: 11.5, P < 0.05; eosinophil median levels, ×109/l: with wheeze: 0.21 vs. without wheeze: 0.05, P < 0.05). The main morbidity crowd is the children under the age of 1 year old. The downregulation of IL2 and the upregulation of IL‐4, IL‐10, IFN‐γ, and IgE happen after RSV infection. J. Med. Virol. 87:323–329, 2015. © 2014 Wiley Periodicals, Inc.
Respiratory Syncytial Virus (RSV) infections are the dominant cause of pneumonia in children. In order to determine the epidemiological characteristics and immune status of children with Respiratory Syncytial Virus, a prospective study was performed among patients with RSV infection. Comparisons between RSV pneumonia group and normal control group, RSV pneumonia group had lower IL-2 (median levels, pg/ml: 3.8 vs. 5.1, P < 0.01), and higher IL-4 (median levels, pg/ml: 3.2 vs. 2.4, P < 0.01), IL-10 (median levels, pg/ml: 12.2 vs. 2.3, P < 0.01), and IFN-γ (median levels, pg/ml: 13.4 vs. 4.6, P < 0.01). The level of IgE among pneumonia patients caused by RSV increased sharply (median levels, mg/L: 48.1 vs. 8.8, P < 0.01). Another amazing finding is that after birth, the degree of IgE of the children infected by RSV increases gradually with age. This effect is at its peak in 0.6 years old. The IgE and eosinophil levels were higher when patients suffered from RSV pneumonia with wheeze (IgE median levels, IU/ml: with wheeze: 72.74 vs. without wheeze: 11.5, P < 0.05; eosinophil median levels, ×10(9) /l: with wheeze: 0.21 vs. without wheeze: 0.05, P < 0.05). The main morbidity crowd is the children under the age of 1 year old. The downregulation of IL2 and the upregulation of IL-4, IL-10, IFN-γ, and IgE happen after RSV infection.Respiratory Syncytial Virus (RSV) infections are the dominant cause of pneumonia in children. In order to determine the epidemiological characteristics and immune status of children with Respiratory Syncytial Virus, a prospective study was performed among patients with RSV infection. Comparisons between RSV pneumonia group and normal control group, RSV pneumonia group had lower IL-2 (median levels, pg/ml: 3.8 vs. 5.1, P < 0.01), and higher IL-4 (median levels, pg/ml: 3.2 vs. 2.4, P < 0.01), IL-10 (median levels, pg/ml: 12.2 vs. 2.3, P < 0.01), and IFN-γ (median levels, pg/ml: 13.4 vs. 4.6, P < 0.01). The level of IgE among pneumonia patients caused by RSV increased sharply (median levels, mg/L: 48.1 vs. 8.8, P < 0.01). Another amazing finding is that after birth, the degree of IgE of the children infected by RSV increases gradually with age. This effect is at its peak in 0.6 years old. The IgE and eosinophil levels were higher when patients suffered from RSV pneumonia with wheeze (IgE median levels, IU/ml: with wheeze: 72.74 vs. without wheeze: 11.5, P < 0.05; eosinophil median levels, ×10(9) /l: with wheeze: 0.21 vs. without wheeze: 0.05, P < 0.05). The main morbidity crowd is the children under the age of 1 year old. The downregulation of IL2 and the upregulation of IL-4, IL-10, IFN-γ, and IgE happen after RSV infection.
Author Pan, Yan-Xiang
Shang, Shi-Qiang
Chen, Xue-Jun
Ye, Qing
Shao, Wen-Xia
Shen, Hong-Qiang
Author_xml – sequence: 1
  givenname: Qing
  surname: Ye
  fullname: Ye, Qing
  organization: Clinical Laboratory, The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China
– sequence: 2
  givenname: Wen-Xia
  surname: Shao
  fullname: Shao, Wen-Xia
  organization: Clinical Laboratory, Hangzhou First People's Hospital, Hangzhou, China
– sequence: 3
  givenname: Shi-Qiang
  surname: Shang
  fullname: Shang, Shi-Qiang
  email: Correspondence to: Shi-Qiang Shang, Clinical Laboratory, The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China., yeqingkaoyan@163.com
  organization: Clinical Laboratory, The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China
– sequence: 4
  givenname: Yan-Xiang
  surname: Pan
  fullname: Pan, Yan-Xiang
  organization: Clinical Laboratory, The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China
– sequence: 5
  givenname: Hong-Qiang
  surname: Shen
  fullname: Shen, Hong-Qiang
  organization: Clinical Laboratory, The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China
– sequence: 6
  givenname: Xue-Jun
  surname: Chen
  fullname: Chen, Xue-Jun
  organization: Clinical Laboratory, The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25123681$$D View this record in MEDLINE/PubMed
BookMark eNqN0UFPFDEYBuDGYGQBD_4BM4kXPQy0nU47czQEV8iqCa5ws_m281W6zkyXdkacf09xgQOJxlMvz_sm_d49stP7Hgl5xegho5Qfrbtfh1xQoZ6RGaO1zGuq2A6ZUSZkLiUrd8lejGtKaVVz_oLs8pLxQlZsRr6fbFyDnfOt_-EMtJm5ggBmwODi4EzMoG8y13Vjj1kcYBhj5m1Crm0C9tmNG66yc4wbF2DwYcq-Tr2ZBpeKLlwY4wF5bqGN-PL-3SffPpwsjz_miy_z0-P3i9yIWqi8FKVhgJyXgBY4M1AKVdZN01jK0VpVNgByxYyhVUMLu7KVRcWMUsCgRlXsk7fb3k3w1yPGQXcuGmxb6NGPUTMpuOSs5tV_0KIWlWKqSPTNE7r2Y-jTR-6UrARVVCT1-l6Nqw4bvQmugzDphyMn8G4LTPAxBrSPhFF9N6BOA-o_AyZ79MQal87ufD8EcO2_Ejeuxenv1frs08VDIt8m0sT4-zEB4aeWqlClvvw812fzxZIt6aUuilu2VLw9
CitedBy_id crossref_primary_10_1038_pr_2016_267
crossref_primary_10_1016_j_jcv_2024_105679
crossref_primary_10_1016_j_cytogfr_2022_10_001
crossref_primary_10_1002_jmv_29758
crossref_primary_10_1128_CMR_00090_16
crossref_primary_10_1016_j_cyto_2018_07_019
crossref_primary_10_21508_1027_4065_2020_65_6_166_174
crossref_primary_10_5812_ijp_3807
crossref_primary_10_1007_s11356_016_7228_6
crossref_primary_10_1007_s11908_016_0516_y
crossref_primary_10_1371_journal_pone_0127767
crossref_primary_10_2147_IDR_S387479
crossref_primary_10_4168_aard_2016_4_2_126
crossref_primary_10_1016_j_biopha_2021_112184
crossref_primary_10_1186_s12985_022_01949_1
crossref_primary_10_3390_pathogens8030106
crossref_primary_10_21053_ceo_2022_01004
crossref_primary_10_1080_14787210_2024_2403147
crossref_primary_10_1097_PCC_0000000000001092
crossref_primary_10_1111_jpc_12985
crossref_primary_10_3390_genes14051101
Cites_doi 10.1371/journal.pone.0098745
10.1177/1087057110362099
10.1038/nature06020
10.1378/chest.121.6.1782
10.1038/nm.2896
10.4049/jimmunol.150.11.4754
10.1371/journal.pone.0090515
10.1002/jmv.23747
10.1002/jmv.21457
10.1097/01.inf.0000243214.80794.3a
10.1002/jmv.21242
10.1007/s00408-011-9349-5
10.1084/jem.184.1.19
10.1002/jmv.23330
10.1093/gerona/63.8.879
10.1111/j.1398-9995.2004.00526.x
10.4049/jimmunol.1002677
10.1002/ppul.20273
10.1186/1465-9921-11-14
10.1016/j.jinf.2013.12.010
10.3201/eid0703.017301
10.1155/2014/986527
10.1111/j.1442-200X.2007.02509.x
10.1111/cei.12059
10.1002/eji.200425274
10.1542/peds.2006-2223
10.1016/j.molimm.2007.09.007
10.1371/journal.ppat.0030151
10.1016/j.jaut.2011.01.001
10.1136/thoraxjnl-2011-200598
ContentType Journal Article
Copyright 2014 Wiley Periodicals, Inc.
Copyright_xml – notice: 2014 Wiley Periodicals, Inc.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
RC3
7X8
7T5
DOI 10.1002/jmv.24047
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
Immunology Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
Immunology Abstracts
DatabaseTitleList Genetics Abstracts
AIDS and Cancer Research Abstracts
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1096-9071
EndPage 329
ExternalDocumentID 3528928631
25123681
10_1002_jmv_24047
JMV24047
ark_67375_WNG_JGLT1T0W_3
Genre article
Journal Article
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3O-
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AI.
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
ECGQY
EJD
ELTNK
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V2E
VH1
W8V
W99
WBKPD
WHG
WIB
WIH
WIJ
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WUP
WXI
WXSBR
WYISQ
X7M
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
RC3
7X8
7T5
ID FETCH-LOGICAL-c4947-545c1ae225aefa21ca54759dddf02eff75daa6b1cc08d03fbf8fe71c77a1a9e73
IEDL.DBID DR2
ISSN 0146-6615
1096-9071
IngestDate Thu Jul 10 22:32:41 EDT 2025
Thu Jul 10 23:21:43 EDT 2025
Sat Jul 26 02:24:15 EDT 2025
Mon Jul 21 05:22:48 EDT 2025
Tue Jul 01 02:24:32 EDT 2025
Thu Apr 24 23:07:57 EDT 2025
Wed Jan 22 16:45:32 EST 2025
Wed Oct 30 09:47:48 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords allergy
immunoglobulin E
respiratory syncytial virus
immune regulation
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2014 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4947-545c1ae225aefa21ca54759dddf02eff75daa6b1cc08d03fbf8fe71c77a1a9e73
Notes ArticleID:JMV24047
istex:AF0B9B1A06FB15E333B5B726292A586D86D13B67
ark:/67375/WNG-JGLT1T0W-3
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 25123681
PQID 1636840704
PQPubID 105515
PageCount 7
ParticipantIDs proquest_miscellaneous_1642621928
proquest_miscellaneous_1639487173
proquest_journals_1636840704
pubmed_primary_25123681
crossref_primary_10_1002_jmv_24047
crossref_citationtrail_10_1002_jmv_24047
wiley_primary_10_1002_jmv_24047_JMV24047
istex_primary_ark_67375_WNG_JGLT1T0W_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2015
PublicationDateYYYYMMDD 2015-02-01
PublicationDate_xml – month: 02
  year: 2015
  text: February 2015
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: London
PublicationTitle Journal of medical virology
PublicationTitleAlternate J. Med. Virol
PublicationYear 2015
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Hyvarinen MK, Kotaniemi-Syrjanen A, Reijonen TM, Korhonen K, Korppi MO. 2005. Teenage asthma after severe early childhood wheezing: An 11-year prospective follow-up. Pediatr Pulmonol 40:316-323.
Selvaggi C, Pierangeli A, Fabiani M, Spano L, Nicolai A, Papoff P, Moretti C, Midulla F, Antonelli G, Scagnolari C. 2014. Interferon lambda 1-3 expression in infants hospitalized for RSV or HRV associated bronchiolitis. J Infect 68:467-477.
Sharma R, Fu SM, Ju S-T. 2011a. IL-2: A two-faced master regulator of autoimmunity. J Autoimmun 36:91-97.
Ye Q, Shao WX, Xu XJ, Yang YZ. 2014a. The clinical application value of cytokines in treating infectious diseases. Plos ONE 9:e98745.
Dowell SF. 2001. Seasonal variation in host susceptibility and cycles of certain infectious diseases. Emerg Infect Dis 7:369-374.
Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, Thomson A, British Thoracic Soc Stand C. 2011. British Thoracic Society guidelines for the management of community acquired pneumonia in children: Update 2011. Thorax 66:II1-II23.
Cassimos DC, Tsalkidis A, Tripsianis GA, Stogiannidou A, Anthracopoulos M, Ktenidou-Kartali S, Aivazis V, Gardikis S, Chatzimichael A. 2008. Asthma, lung function and sensitization in school children with a history of bronchiolitis. Pediatr Int 50:51-56.
Karadag-Oncel E, Ciblak MA, Ozsurekci Y, Badur S, Ceyhan M. 2014. Viral etiology of influenza-like illnesses during the influenza season between December 2011 and April 2012. J Med Virol 86:865-871.
Khamis FA, Al-Kobaisi MF, Al-Areimi WS, Al-Kindi H, Al-Zakwani I. 2012. Epidemiology of respiratory virus infections among infants and young children admitted to hospital in Oman. J Med Virol 84:1323-1329.
Kim CK, Callaway Z, Koh YY, Kim SH, Fujisawa T. 2012. Airway IFN-gamma production during RSV bronchiolitis is associated with eosinophilic inflammation. Lung 190:183-188.
Rafiefard F, Yun ZB, Orvell C. 2008. Epidemiologic characteristics and seasonal distribution of human metapneumovirus infections in five epidemic seasons in Stockholm, Sweden, 2002-2006. J Med Virol 80:1631-1638.
Richens JL, Urbanowicz RA, Metcalf R, Corne J, O'Shea P, Fairclough L. 2010. Quantitative validation and comparison of multiplex cytokine kits. J Biomol Screen 15:562-568.
Poulsen A, Stensballe LG, Nielsen J, Benn CS, Balde A, Roth A, Lisse IM, Aaby P. 2006. Long-term consequences of respiratory syncytial virus acute lower respiratory tract infection in early childhood in Guinea-Bissau. Pediatr Infect Dis 25:1025-1031.
Sun L, Cornell TT, LeVine A, Berlin AA, Hinkovska-Galcheva V, Fleszar AJ, Lukacs NW, Shanley TP. 2013. Dual role of interleukin-10 in the regulation of respiratory syncitial virus (RSV)-induced lung inflammation. Clin Exp Immunol 172:263-279.
Groux H, Bigler M, De Vries J, Roncarolo M-G. 1996. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 184:19-29.
Kitayama D, Sakamoto A, Arima M, Hatano M, Miyazaki M, Tokuhisa T. 2008. A role for Bcl6 in sequential class switch recombination to IgE in B cells stimulated with IL-4 and IL-21. Mol Immunol 45:1337-1345.
Sharma R, Sharma PR, Kim Y-C, Leitinger N, Lee JK, Fu SM, Ju S-T. 2011b. IL-2-controlled expression of multiple T cell trafficking genes and Th2 cytokines in the regulatory T cell-deficient scurfy mice: Implication to multiorgan inflammation and control of skin and lung inflammation. J Immunol 186:1268-1278.
Yan CT, Boboila C, Souza EK, Franco S, Hickernell TR, Murphy M, Gumaste S, Geyer M, Zarrin AA, Manis JP. 2007. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 449:478-482.
Masoli M, Fabian D, Holt S, Beasley R. 2004. The global burden of asthma: Executive summary of the GINA Dissemination Committee report. Allergy 59:469-478.
Krishnamoorthy N, Khare A, Oriss TB, Raundhal M, Morse C, Yarlagadda M, Wenzel SE, Moore ML, Peebles RS, Ray A, Ray P. 2012. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nat Med 18:1525-1530.
de Waal Malefyt R, Yssel H, de Vries JE. 1993. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150:4754-4765.
Kraft M, Cassell GH, Pak J, Martin RJ. 2002. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthmaeffect of clarithromycin. Chest 121:1782-1788.
de la Rosa M, Rutz S, Dorninger H, Scheffold A. 2004. Interleukin-2 is essential for CD4+ CD25+ regulatory T cell function. Eur J Immunol 34:2480-2488.
Ye Q, Xu X-J, Shao W-X, Pan Y-X, Chen X-J. 2014b. Mycoplasma pneumoniae infection in children is a risk factor for developing allergic diseases. Sci World J 2014:986527.
Diagnosis So, Bronchiolitis Mo. 2006. Diagnosis and management of Bronchiolitis. Pediatrics 118:1774-1793.
Hirsh S, Hindiyeh M, Kolet L, Regev L, Sherbany H, Yaary K, Mendelson E, Mandelboim M. 2014. Epidemiological changes of Respiratory Syncytial Virus (RSV) infections in Israel. PLoS ONE 9:e90515.
Fabbiani M, Terrosi C, Martorelli B, Valentini M, Bernini L, Cellesi C, Cusi MG. 2009. Epidemiological and clinical study of viral respiratory tract infections in children from Italy. J Med Virol 81:750-756.
Leng SX, McElhaney JE, Walston JD, Xie DX, Fedarko NS, Kuchel GA. 2008. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 63:879-884.
Siegle JS, Hansbro N, Herbert C, Rosenberg HF, Domachowske JB, Asquith KL, Foster PS, Kumar RK. 2010. Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice. Respir Res 11:14.
Lowen AC, Mubareka S, Steel J, Palese P. 2007. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 3:e151.
2010; 11
2010; 15
2007; 449
2009; 81
1996; 184
2005; 40
2014; 68
2012; 18
2008; 50
2006; 118
2011a; 36
2014; 86
2011b; 186
2001; 7
2002; 121
2012; 190
2004; 59
2004; 34
2006; 25
1993; 150
2011; 66
2008; 45
2008; 63
2014b; 2014
2007; 3
2014; 9
2014a; 9
2013; 172
2008; 80
2012; 84
e_1_2_5_27_1
e_1_2_5_28_1
e_1_2_5_25_1
e_1_2_5_26_1
e_1_2_5_23_1
e_1_2_5_24_1
e_1_2_5_21_1
e_1_2_5_22_1
e_1_2_5_29_1
e_1_2_5_20_1
e_1_2_5_15_1
e_1_2_5_14_1
de Waal Malefyt R (e_1_2_5_4_1) 1993; 150
e_1_2_5_17_1
e_1_2_5_9_1
e_1_2_5_16_1
e_1_2_5_8_1
e_1_2_5_11_1
e_1_2_5_7_1
e_1_2_5_10_1
e_1_2_5_6_1
e_1_2_5_13_1
e_1_2_5_5_1
e_1_2_5_12_1
e_1_2_5_3_1
e_1_2_5_2_1
e_1_2_5_19_1
e_1_2_5_18_1
e_1_2_5_30_1
e_1_2_5_31_1
References_xml – reference: Richens JL, Urbanowicz RA, Metcalf R, Corne J, O'Shea P, Fairclough L. 2010. Quantitative validation and comparison of multiplex cytokine kits. J Biomol Screen 15:562-568.
– reference: Fabbiani M, Terrosi C, Martorelli B, Valentini M, Bernini L, Cellesi C, Cusi MG. 2009. Epidemiological and clinical study of viral respiratory tract infections in children from Italy. J Med Virol 81:750-756.
– reference: Diagnosis So, Bronchiolitis Mo. 2006. Diagnosis and management of Bronchiolitis. Pediatrics 118:1774-1793.
– reference: de Waal Malefyt R, Yssel H, de Vries JE. 1993. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150:4754-4765.
– reference: Kim CK, Callaway Z, Koh YY, Kim SH, Fujisawa T. 2012. Airway IFN-gamma production during RSV bronchiolitis is associated with eosinophilic inflammation. Lung 190:183-188.
– reference: Karadag-Oncel E, Ciblak MA, Ozsurekci Y, Badur S, Ceyhan M. 2014. Viral etiology of influenza-like illnesses during the influenza season between December 2011 and April 2012. J Med Virol 86:865-871.
– reference: Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, Thomson A, British Thoracic Soc Stand C. 2011. British Thoracic Society guidelines for the management of community acquired pneumonia in children: Update 2011. Thorax 66:II1-II23.
– reference: Ye Q, Xu X-J, Shao W-X, Pan Y-X, Chen X-J. 2014b. Mycoplasma pneumoniae infection in children is a risk factor for developing allergic diseases. Sci World J 2014:986527.
– reference: Siegle JS, Hansbro N, Herbert C, Rosenberg HF, Domachowske JB, Asquith KL, Foster PS, Kumar RK. 2010. Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice. Respir Res 11:14.
– reference: Leng SX, McElhaney JE, Walston JD, Xie DX, Fedarko NS, Kuchel GA. 2008. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 63:879-884.
– reference: Dowell SF. 2001. Seasonal variation in host susceptibility and cycles of certain infectious diseases. Emerg Infect Dis 7:369-374.
– reference: de la Rosa M, Rutz S, Dorninger H, Scheffold A. 2004. Interleukin-2 is essential for CD4+ CD25+ regulatory T cell function. Eur J Immunol 34:2480-2488.
– reference: Kitayama D, Sakamoto A, Arima M, Hatano M, Miyazaki M, Tokuhisa T. 2008. A role for Bcl6 in sequential class switch recombination to IgE in B cells stimulated with IL-4 and IL-21. Mol Immunol 45:1337-1345.
– reference: Sun L, Cornell TT, LeVine A, Berlin AA, Hinkovska-Galcheva V, Fleszar AJ, Lukacs NW, Shanley TP. 2013. Dual role of interleukin-10 in the regulation of respiratory syncitial virus (RSV)-induced lung inflammation. Clin Exp Immunol 172:263-279.
– reference: Hirsh S, Hindiyeh M, Kolet L, Regev L, Sherbany H, Yaary K, Mendelson E, Mandelboim M. 2014. Epidemiological changes of Respiratory Syncytial Virus (RSV) infections in Israel. PLoS ONE 9:e90515.
– reference: Lowen AC, Mubareka S, Steel J, Palese P. 2007. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 3:e151.
– reference: Rafiefard F, Yun ZB, Orvell C. 2008. Epidemiologic characteristics and seasonal distribution of human metapneumovirus infections in five epidemic seasons in Stockholm, Sweden, 2002-2006. J Med Virol 80:1631-1638.
– reference: Sharma R, Sharma PR, Kim Y-C, Leitinger N, Lee JK, Fu SM, Ju S-T. 2011b. IL-2-controlled expression of multiple T cell trafficking genes and Th2 cytokines in the regulatory T cell-deficient scurfy mice: Implication to multiorgan inflammation and control of skin and lung inflammation. J Immunol 186:1268-1278.
– reference: Hyvarinen MK, Kotaniemi-Syrjanen A, Reijonen TM, Korhonen K, Korppi MO. 2005. Teenage asthma after severe early childhood wheezing: An 11-year prospective follow-up. Pediatr Pulmonol 40:316-323.
– reference: Yan CT, Boboila C, Souza EK, Franco S, Hickernell TR, Murphy M, Gumaste S, Geyer M, Zarrin AA, Manis JP. 2007. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 449:478-482.
– reference: Ye Q, Shao WX, Xu XJ, Yang YZ. 2014a. The clinical application value of cytokines in treating infectious diseases. Plos ONE 9:e98745.
– reference: Khamis FA, Al-Kobaisi MF, Al-Areimi WS, Al-Kindi H, Al-Zakwani I. 2012. Epidemiology of respiratory virus infections among infants and young children admitted to hospital in Oman. J Med Virol 84:1323-1329.
– reference: Sharma R, Fu SM, Ju S-T. 2011a. IL-2: A two-faced master regulator of autoimmunity. J Autoimmun 36:91-97.
– reference: Krishnamoorthy N, Khare A, Oriss TB, Raundhal M, Morse C, Yarlagadda M, Wenzel SE, Moore ML, Peebles RS, Ray A, Ray P. 2012. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nat Med 18:1525-1530.
– reference: Masoli M, Fabian D, Holt S, Beasley R. 2004. The global burden of asthma: Executive summary of the GINA Dissemination Committee report. Allergy 59:469-478.
– reference: Poulsen A, Stensballe LG, Nielsen J, Benn CS, Balde A, Roth A, Lisse IM, Aaby P. 2006. Long-term consequences of respiratory syncytial virus acute lower respiratory tract infection in early childhood in Guinea-Bissau. Pediatr Infect Dis 25:1025-1031.
– reference: Cassimos DC, Tsalkidis A, Tripsianis GA, Stogiannidou A, Anthracopoulos M, Ktenidou-Kartali S, Aivazis V, Gardikis S, Chatzimichael A. 2008. Asthma, lung function and sensitization in school children with a history of bronchiolitis. Pediatr Int 50:51-56.
– reference: Kraft M, Cassell GH, Pak J, Martin RJ. 2002. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthmaeffect of clarithromycin. Chest 121:1782-1788.
– reference: Groux H, Bigler M, De Vries J, Roncarolo M-G. 1996. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 184:19-29.
– reference: Selvaggi C, Pierangeli A, Fabiani M, Spano L, Nicolai A, Papoff P, Moretti C, Midulla F, Antonelli G, Scagnolari C. 2014. Interferon lambda 1-3 expression in infants hospitalized for RSV or HRV associated bronchiolitis. J Infect 68:467-477.
– volume: 68
  start-page: 467
  year: 2014
  end-page: 477
  article-title: Interferon lambda 1‐3 expression in infants hospitalized for RSV or HRV associated bronchiolitis
  publication-title: J Infect
– volume: 45
  start-page: 1337
  year: 2008
  end-page: 1345
  article-title: A role for Bcl6 in sequential class switch recombination to IgE in B cells stimulated with IL‐4 and IL‐21
  publication-title: Mol Immunol
– volume: 84
  start-page: 1323
  year: 2012
  end-page: 1329
  article-title: Epidemiology of respiratory virus infections among infants and young children admitted to hospital in Oman
  publication-title: J Med Virol
– volume: 118
  start-page: 1774
  year: 2006
  end-page: 1793
  article-title: Diagnosis and management of Bronchiolitis
  publication-title: Pediatrics
– volume: 15
  start-page: 562
  year: 2010
  end-page: 568
  article-title: Quantitative validation and comparison of multiplex cytokine kits
  publication-title: J Biomol Screen
– volume: 66
  start-page: II1
  year: 2011
  end-page: II23
  article-title: British Thoracic Society guidelines for the management of community acquired pneumonia in children: Update 2011
  publication-title: Thorax
– volume: 59
  start-page: 469
  year: 2004
  end-page: 478
  article-title: The global burden of asthma: Executive summary of the GINA Dissemination Committee report
  publication-title: Allergy
– volume: 11
  start-page: 14
  year: 2010
  article-title: Early‐life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice
  publication-title: Respir Res
– volume: 3
  start-page: e151
  year: 2007
  article-title: Influenza virus transmission is dependent on relative humidity and temperature
  publication-title: PLoS Pathog
– volume: 50
  start-page: 51
  year: 2008
  end-page: 56
  article-title: Asthma, lung function and sensitization in school children with a history of bronchiolitis
  publication-title: Pediatr Int
– volume: 63
  start-page: 879
  year: 2008
  end-page: 884
  article-title: ELISA and multiplex technologies for cytokine measurement in inflammation and aging research
  publication-title: J Gerontol A Biol Sci Med Sci
– volume: 9
  start-page: e90515
  year: 2014
  article-title: Epidemiological changes of Respiratory Syncytial Virus (RSV) infections in Israel
  publication-title: PLoS ONE
– volume: 40
  start-page: 316
  year: 2005
  end-page: 323
  article-title: Teenage asthma after severe early childhood wheezing: An 11‐year prospective follow‐up
  publication-title: Pediatr Pulmonol
– volume: 2014
  start-page: 986527
  year: 2014b
  article-title: Mycoplasma pneumoniae infection in children is a risk factor for developing allergic diseases
  publication-title: Sci World J
– volume: 121
  start-page: 1782
  year: 2002
  end-page: 1788
  article-title: Mycoplasma pneumoniae and Chlamydia pneumoniae in asthmaeffect of clarithromycin
  publication-title: Chest
– volume: 80
  start-page: 1631
  year: 2008
  end-page: 1638
  article-title: Epidemiologic characteristics and seasonal distribution of human metapneumovirus infections in five epidemic seasons in Stockholm, Sweden, 2002‐2006
  publication-title: J Med Virol
– volume: 36
  start-page: 91
  year: 2011a
  end-page: 97
  article-title: IL‐2: A two‐faced master regulator of autoimmunity
  publication-title: J Autoimmun
– volume: 186
  start-page: 1268
  year: 2011b
  end-page: 1278
  article-title: IL‐2‐controlled expression of multiple T cell trafficking genes and Th2 cytokines in the regulatory T cell‐deficient scurfy mice: Implication to multiorgan inflammation and control of skin and lung inflammation
  publication-title: J Immunol
– volume: 449
  start-page: 478
  year: 2007
  end-page: 482
  article-title: IgH class switching and translocations use a robust non‐classical end‐joining pathway
  publication-title: Nature
– volume: 86
  start-page: 865
  year: 2014
  end-page: 871
  article-title: Viral etiology of influenza‐like illnesses during the influenza season between December 2011 and April 2012
  publication-title: J Med Virol
– volume: 25
  start-page: 1025
  year: 2006
  end-page: 1031
  article-title: Long‐term consequences of respiratory syncytial virus acute lower respiratory tract infection in early childhood in Guinea‐Bissau
  publication-title: Pediatr Infect Dis
– volume: 150
  start-page: 4754
  year: 1993
  end-page: 4765
  article-title: Direct effects of IL‐10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL‐2 production and proliferation
  publication-title: J Immunol
– volume: 7
  start-page: 369
  year: 2001
  end-page: 374
  article-title: Seasonal variation in host susceptibility and cycles of certain infectious diseases
  publication-title: Emerg Infect Dis
– volume: 184
  start-page: 19
  year: 1996
  end-page: 29
  article-title: Interleukin‐10 induces a long‐term antigen‐specific anergic state in human CD4+ T cells
  publication-title: J Exp Med
– volume: 190
  start-page: 183
  year: 2012
  end-page: 188
  article-title: Airway IFN‐gamma production during RSV bronchiolitis is associated with eosinophilic inflammation
  publication-title: Lung
– volume: 34
  start-page: 2480
  year: 2004
  end-page: 2488
  article-title: Interleukin‐2 is essential for CD4+ CD25+ regulatory T cell function
  publication-title: Eur J Immunol
– volume: 81
  start-page: 750
  year: 2009
  end-page: 756
  article-title: Epidemiological and clinical study of viral respiratory tract infections in children from Italy
  publication-title: J Med Virol
– volume: 172
  start-page: 263
  year: 2013
  end-page: 279
  article-title: Dual role of interleukin‐10 in the regulation of respiratory syncitial virus (RSV)‐induced lung inflammation
  publication-title: Clin Exp Immunol
– volume: 18
  start-page: 1525
  year: 2012
  end-page: 1530
  article-title: Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma
  publication-title: Nat Med
– volume: 9
  start-page: e98745
  year: 2014a
  article-title: The clinical application value of cytokines in treating infectious diseases
  publication-title: Plos ONE
– ident: e_1_2_5_30_1
  doi: 10.1371/journal.pone.0098745
– ident: e_1_2_5_23_1
  doi: 10.1177/1087057110362099
– ident: e_1_2_5_29_1
  doi: 10.1038/nature06020
– ident: e_1_2_5_16_1
  doi: 10.1378/chest.121.6.1782
– ident: e_1_2_5_17_1
  doi: 10.1038/nm.2896
– volume: 150
  start-page: 4754
  year: 1993
  ident: e_1_2_5_4_1
  article-title: Direct effects of IL‐10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL‐2 production and proliferation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.150.11.4754
– ident: e_1_2_5_10_1
  doi: 10.1371/journal.pone.0090515
– ident: e_1_2_5_12_1
  doi: 10.1002/jmv.23747
– ident: e_1_2_5_7_1
  doi: 10.1002/jmv.21457
– ident: e_1_2_5_21_1
  doi: 10.1097/01.inf.0000243214.80794.3a
– ident: e_1_2_5_22_1
  doi: 10.1002/jmv.21242
– ident: e_1_2_5_14_1
  doi: 10.1007/s00408-011-9349-5
– ident: e_1_2_5_8_1
  doi: 10.1084/jem.184.1.19
– ident: e_1_2_5_13_1
  doi: 10.1002/jmv.23330
– ident: e_1_2_5_18_1
  doi: 10.1093/gerona/63.8.879
– ident: e_1_2_5_20_1
  doi: 10.1111/j.1398-9995.2004.00526.x
– ident: e_1_2_5_26_1
  doi: 10.4049/jimmunol.1002677
– ident: e_1_2_5_11_1
  doi: 10.1002/ppul.20273
– ident: e_1_2_5_27_1
  doi: 10.1186/1465-9921-11-14
– ident: e_1_2_5_24_1
  doi: 10.1016/j.jinf.2013.12.010
– ident: e_1_2_5_6_1
  doi: 10.3201/eid0703.017301
– ident: e_1_2_5_31_1
  doi: 10.1155/2014/986527
– ident: e_1_2_5_2_1
  doi: 10.1111/j.1442-200X.2007.02509.x
– ident: e_1_2_5_28_1
  doi: 10.1111/cei.12059
– ident: e_1_2_5_3_1
  doi: 10.1002/eji.200425274
– ident: e_1_2_5_5_1
  doi: 10.1542/peds.2006-2223
– ident: e_1_2_5_15_1
  doi: 10.1016/j.molimm.2007.09.007
– ident: e_1_2_5_19_1
  doi: 10.1371/journal.ppat.0030151
– ident: e_1_2_5_25_1
  doi: 10.1016/j.jaut.2011.01.001
– ident: e_1_2_5_9_1
  doi: 10.1136/thoraxjnl-2011-200598
SSID ssj0008922
Score 2.2466693
Snippet Respiratory Syncytial Virus (RSV) infections are the dominant cause of pneumonia in children. In order to determine the epidemiological characteristics and...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 323
SubjectTerms allergy
Antibodies, Viral - blood
Child
Child, Preschool
Children & youth
Cytokines - blood
Epidemiology
Female
Humans
immune regulation
immunoglobulin E
Immunoglobulin E - blood
Immunology
Infant
Male
Pneumonia, Viral - epidemiology
Pneumonia, Viral - pathology
Prospective Studies
Respiratory syncytial virus
Respiratory Syncytial Virus Infections - epidemiology
Respiratory Syncytial Virus Infections - pathology
Respiratory Syncytial Virus, Human - immunology
Risk Factors
Virology
Title Epidemiological characteristics and immune status of children with Respiratory Syncytial Virus
URI https://api.istex.fr/ark:/67375/WNG-JGLT1T0W-3/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.24047
https://www.ncbi.nlm.nih.gov/pubmed/25123681
https://www.proquest.com/docview/1636840704
https://www.proquest.com/docview/1639487173
https://www.proquest.com/docview/1642621928
Volume 87
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwEB5VRUK8UG5SCjIIIV6yjRMn3ognhHpoxfahbI8HhGU7tlTaZqvdDWr59czkWi0qCPEWKRPFxxyfPZ7PAG-5TTzGrSKMnchD4bM4zKWJEMgVReENhgxB9c7jg2z_SIxO09M1-NDVwjT8EP2GG1lG7a_JwLWZby9JQ79f_hhgOBJUSU5ntQgQHS6po4Z5k0FATxBiDEo7VqEo3u6_XIlFd2hYr28Dmqu4tQ48uxvwtWtyc97kfFAtzMD-_I3N8T_79ADut4CUfWw06CGsufIR3B23KffH8G1neYcsTSizqxTPTJcFO6MqE8eoOqmas6lnXY04o31edrjM57MvN-jO0a1csOOzWTV_Ake7O5NP-2F7KUNoRS5kiIjLcu3QDWjndcytTokykGY2ip33Mi20zgy3NhoWUeKNH3onuZVSc507mTyF9XJauufARBYZ5zE-EgqyNjM6TnA5q1FHXJ4VMoD33fQo2zKW08UZF6rhWo4VjpeqxyuAN73oVUPTcZvQu3qOewk9O6dzbTJVJwd7arT3ecIn0YlKAtjqlEC1Jj1XCFyJGEdGIoDX_Ws0Rsqw6NJNq1omxxUgl8nfZOgSAATWwwCeNQrWN4jAJv6FY89rNflzX9RofFw_bP676Au4h3Avbc6cb8H6Yla5lwipFuZVbTu_AF-8HeM
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VVgIuvAuGAgsCxMWp3xsfekD0kaZJDiV9nNiu17tSaXFQEreU39S_wn9ixq8oqCAuPXCz5JG9653Ht-uZbwDeuMo3GLdS29NBbAcm8uyYJw4CuTRNTYIhI6B65_4g6uwF3cPwcAEu61qYkh-iOXAjyyj8NRk4HUivzlhDv3w9a2E8CniVUrmjL85xwzZZ217H1X3reZsbw48du-opYKsgDriNgEG5UqMWS22k5yoZEuMdDczxtDE8TKWMElcpp506vklM22juKs6lK2PNfXzuDViiDuLE1L--OyOrasflPwv0PTZGvbDmMXK81Waoc9FviRby-1XQdh4pF6Fu8y78rD9SmeFy0sqnSUv9-I0_8n_5ivfgToW52YfSSO7Dgs4ewM1-lVXwED5vzNrkks4yNc9izWSWsmMqpNGMCrDyCRsZVpfBMzrKZruzlAX26QIjFnrOU7Z_PM4nj2DvWma3DIvZKNNPgAWRk2iDEICAnlJRIj0fd-wSzUDHUcoteF_rg1AVKTv1BjkVJZ20J3B9RLE-FrxuRL-VTCRXCb0rlKqRkOMTSt3joTgYbInuVm_oDp0D4VuwUmudqLzWRCA2J-4f7gQWvGpuo7-hn0gy06O8kIlxk-ty_28y1OcA9w5tCx6XGt0MiPA0vsXFmRd6-ee5iG5_v7h4-u-iL-FWZ9jvid72YOcZ3EZ0G5Yp9iuwOB3n-jkiyGnyojBcBkfXreO_ALJvf5c
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VVqq48IYaCiwIEBenXr82PnBATdM2bSJU0seJ7XofUmlxqiQGyl_ir_CjOutXFFQQlx64WfLI3vXO49v1zDcAr6gMDMYt5fo6TNzQxL6bsNRDIKeUMimGjNDWO_cH8dZ-2DuKjhbgZ10LU_JDNAdu1jIKf20N_FyZtRlp6OcvX1sYjkJWZVTu6ItvuF-bvNvu4OK-9v3uxnB9y61aCrgyTELmIl6QVGhUYqGN8KkUkSW8s-PyfG0Mi5QQcUql9NrKC0xq2kYzKhkTVCSaBfjcG7AUxl5i-0R09mZcVe2k_GWBrsfFoBfVNEaev9YMdS74Ldl1_H4Vsp0HykWk696GX_U3KhNcTlv5NG3JH7_RR_4nH_EO3KoQN3lfmshdWNDZPVjuVzkF9-HTxqxJrtVYIuc5rInIFDmxZTSa2PKrfEJGhtRF8MQeZJO9WcIC-XiB8Qr95hk5OBnnkwewfy2zewiL2SjTK0BQTVJtEABYmCdlnAo_wP26QCPQSayYA29rdeCyomS3nUHOeEkm7XNcH16sjwMvG9HzkofkKqE3hU41EmJ8ahP3WMQPB5u8t7k7pEPvkAcOrNZKxyufNeGIzC3zD_NCB140t9Hb2F9IItOjvJBJcItLWfA3GdvlAHcObQcelQrdDMiiaXwLxZkXavnnufBe_6C4ePzvos9h-UOny3e3BztP4CZC26jMr1-Fxek4108RPk7TZ4XZEji-bhW_BLJsfkY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiological+characteristics+and+immune+status+of+children+with+Respiratory+Syncytial+Virus&rft.jtitle=Journal+of+medical+virology&rft.au=Ye%2C+Qing&rft.au=Shao%2C+Wen-Xia&rft.au=Shang%2C+Shi-Qiang&rft.au=Pan%2C+Yan-Xiang&rft.date=2015-02-01&rft.eissn=1096-9071&rft.volume=87&rft.issue=2&rft.spage=323&rft_id=info:doi/10.1002%2Fjmv.24047&rft_id=info%3Apmid%2F25123681&rft.externalDocID=25123681
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0146-6615&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0146-6615&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0146-6615&client=summon